Free shipping on all orders over $ 500

PF-06882961

Cat. No. M10311
PF-06882961 Structure
Synonym:

Danuglipron; PF06882961

Size Price Availability Quantity
5mg USD 204.3  USD227 In stock
10mg USD 362.7  USD403 In stock
25mg USD 611.1  USD679 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
  • Current batch:
  • Purity >99%
  • COA
  • MSDS
Biological Activity

PF-06882961 is a potent, orally bioavailable agonist of the glucagon-like peptide-1 receptor (GLP-1R) agonist. PF-06882961 stimulates cAMP accumulation in CHO cells expressing both the human and monkey GLP-1Rs with comparable EC50 values. PF-06882961 shows mild to moderate damage to the heart, moderate to severe effects on the thymus gland (which helps with managing infection), mild to moderate stomach ulcers at the highest dose level given in the rat.

Protocol
Cell Experiment
Cell lines HEK293 cells
Preparation method HEK293 cells stably expressing hGLP-1R fused to green fluorescent protein (GFP) (400,000 cells per well) are cultured onto 6 well plates for 24 hours and stimulated with PF-06882961 for 30 minutes. An agonist concentration of 1 μM shown to induce maximal internalization is chosen for these studies. In selected wells, cells are washed three times with PBS containing 0.1 % BSA and incubated at 37 °C for an additional 2 hours to assess reversibility of the endocytosis process. Cells are then fixed with 4% paraformaldehyde for 15 minutes at room temperature followed by three washes with PBS containing 0.1% BSA.
Concentrations 1 μM
Incubation time 30 minutes
Animal Experiment
Animal models cynomolgus monkeys
Formulation -
Dosages 1 mg/kg iv; 5 mg/kg, 100 mg/kg PO
Administration iv, PO
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

Chemical Information
Molecular Weight 555.6
Formula C31H30FN5O4
CAS Number 2230198-02-2
Purity >99%
Solubility DMSO 100 mg/mL
Storage at -20°C
References

Peptidyl and Non-Peptidyl Oral Glucagon-Like Peptide-1 Receptor Agonists
Hun Jee Choe, et al. Endocrinol Metab (Seoul). 2021 Feb;36(1):22-29. PMID: 33677922.

Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R)
Maria Mendez, et al. J Med Chem. 2020 Mar 12;63(5):2292-2307. PMID: 31596080.

A small-molecule oral agonist of the human glucagon-like peptide-1 receptor
David A. Griffith, et al. bioRxiv. 2020 Sep.

Related Glucagon Receptor Products
Teduglutide

Teduglutide is a glucagon-like peptide-2 (GLP- 2) receptor agonist used for the treatment of short-bowel syndrome.

NNC0640

NNC0640 is a potent, negative allosteric modulator (NAM) of human G-protein-coupled glucagon receptor (GCGR) with IC50 of 69.2 nM.

Avexitide (Exendin 9-39)

Avexitide (Exendin 9-39) is a specific and competitive GLP-1 receptor antagonist.

Cotadutide acetate

Cotadutide acetate is a potent peptide dual agonist of glucagon-like peptide-1 (GLP-1) and glucagon receptor, with EC50 values of 6.9 pM and 10.2 pM, respectively.

Tirzepatide TFA

Tirzepatide TFA (LY3298176 TFA) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.

  Catalog
Abmole Inhibitor Catalog 2017




Keywords: PF-06882961, Danuglipron; PF06882961 supplier, Glucagon Receptor, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.